Senseonics Holdings (SENS) Net Income Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -126.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.77% |
| Dec 31, 2025 | -34.10% |
| Sep 30, 2025 | 18.50% |
| Jun 30, 2025 | 28.90% |
| Mar 31, 2025 | 24.63% |
| Dec 31, 2024 | 9.97% |
| Sep 30, 2024 | -19.93% |
| Jun 30, 2024 | 2.30% |
| Mar 31, 2024 | 18.74% |
| Dec 31, 2023 | 32.66% |
| Sep 30, 2023 | 8.43% |
| Jun 30, 2023 | 2.06% |
| Mar 31, 2023 | -38.68% |
| Dec 31, 2022 | -36.00% |
| Sep 30, 2022 | -10.29% |
| Jun 30, 2022 | -8.27% |
| Mar 31, 2022 | -9.12% |
| Dec 31, 2021 | -26.27% |
| Sep 30, 2021 | -22.93% |
| Jun 30, 2021 | -22.42% |
| Mar 31, 2021 | 67.98% |
| Dec 31, 2020 | 67.20% |
| Sep 30, 2020 | 50.50% |
| Jun 30, 2020 | 55.61% |
| Mar 31, 2020 | -53.94% |
| Dec 31, 2019 | -53.45% |
| Sep 30, 2019 | -43.87% |
| Jun 30, 2019 | -64.14% |
| Mar 31, 2019 | -78.00% |
| Dec 31, 2018 | -80.06% |
| Sep 30, 2018 | -29.98% |
| Jun 30, 2018 | -78.31% |
| Mar 31, 2018 | -34.10% |
| Dec 31, 2017 | -64.74% |
| Sep 30, 2017 | -58.40% |
| Jun 30, 2017 | -4.95% |
| Mar 31, 2017 | -16.59% |
| Dec 31, 2016 | -21.97% |
| Sep 30, 2016 | -27.98% |
| Jun 30, 2016 | -64.37% |
| Mar 31, 2016 | -96.49% |